Home Cart 0 Sign in  

[ CAS No. 62124-43-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 62124-43-0
Chemical Structure| 62124-43-0
Structure of 62124-43-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 62124-43-0 ]

Related Doc. of [ 62124-43-0 ]

Alternatived Products of [ 62124-43-0 ]

Product Details of [ 62124-43-0 ]

CAS No. :62124-43-0 MDL No. :MFCD00763284
Formula : C9H6ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :RQAIEHDXUZPMBJ-UHFFFAOYSA-N
M.W : 179.60 Pubchem ID :10997626
Synonyms :

Calculated chemistry of [ 62124-43-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.95
TPSA : 26.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.32
Log Po/w (XLOGP3) : 2.96
Log Po/w (WLOGP) : 3.0
Log Po/w (MLOGP) : 1.63
Log Po/w (SILICOS-IT) : 3.09
Consensus Log Po/w : 2.6

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.43
Solubility : 0.0666 mg/ml ; 0.000371 mol/l
Class : Soluble
Log S (Ali) : -3.17
Solubility : 0.122 mg/ml ; 0.000677 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.37
Solubility : 0.00766 mg/ml ; 0.0000427 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.33

Safety of [ 62124-43-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 62124-43-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 62124-43-0 ]
  • Downstream synthetic route of [ 62124-43-0 ]

[ 62124-43-0 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 1006-68-4 ]
  • [ 62124-43-0 ]
YieldReaction ConditionsOperation in experiment
90.9%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 0.5 h;
Stage #2: With hexachloroethane In tetrahydrofuran at 25℃; for 12 h;
[0819] to a solution of 5-phenyloxazole (800 mg, 5.51 mmol) in THF (10 ml) was added n-BuLi (2.5 m, 2.76 ml) drop-wise at -78 °C and stirred for 30 min, then hexachloroethane (1.96 g, 8.27 mmol) in THF (2 ml) was added, the reaction mixture was slowly warmed to 25 °C and stirred for 12 h. The mixture was poured into ice- water (20 ml) and extracted ethyl acetate (10 ml x 2), the organic phases were washed with brine (10 ml), dried over Na2SO4, filtered and concentrated, the residue was purified by silica gel column (petroleum ether: ethyl acetate = 10: 1) to give 114a (900 mg, yield: 90.9percent) as yellow oil. 1H NMR (400mhz, CDCl3) δ 7.58 (d, = 7.3 hz, 2h), 7.45 - 7.38 (m, 2h), 7.38 - 7.31 (m, 1h), 7.27 (s, 1h).
49%
Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 0.25 h;
Stage #2: With hexachloroethane In tetrahydrofuran at -78 - 20℃; for 2 h;
[00208] To a round bottom flask was added 5-phenyloxazole (1.0 gm, 6.89 mmol) and THF (10 mL). The reaction was cooled to -78 °C. Then 2.5 M nBuLi (3.03 mL, 7.58 mmol) was added to the reaction at -78 °C. The reaction turned to deep red color. After 15 min, hexachloroethane (1.170 mL, 10.33 mmol) was added at -78 °C. The reaction was slowly warmed to rt over 2 hrs and then was poured onto ice. The resulting solution was extracted with EtO Ac (2 x 30ml). The combined EtO Ac layers were washed with saturated aqueous NaCl, dried over MgS04, filtered and concentrated. The resulting residue was purified using silica gel chromatography (ISCO system) eluting with a gradient of 0-100percent EtO Ac/Hex to give the product, 2-chloro-5-phenyloxazole, (600 mg, 3.34 mmol, 49 percent yield) as a light pale liquid. Anal. Calcd. for C9H6C1N0 m/z 179.1, found: 180.1 (M+H)+; 'H NMR (500 MHz, CDC13) δ ppm 7.60 (d, J=7.15 Hz, 2 H), 7.43 (t, J=7.42 Hz, 2 H), 7.38 - 7.33 (m, 1 H), 7.29 (s, 1 H); 13C NMR (126 MHz, CDCl3) 5 ppm 153.78, 146.16, 129.01, 126.93, 124.03, 123.31.
Reference: [1] Organic Letters, 2005, vol. 7, # 15, p. 3351 - 3354
[2] Patent: WO2018/64119, 2018, A1, . Location in patent: Paragraph 0819
[3] Patent: WO2013/12827, 2013, A1, . Location in patent: Paragraph 00208
[4] Journal of Organic Chemistry, 1996, vol. 61, # 16, p. 5192 - 5193
  • 2
  • [ 16172-23-9 ]
  • [ 62124-43-0 ]
YieldReaction ConditionsOperation in experiment
18% at 0 - 120℃; for 3 h; Step a:
Preparation of 2-chloro-5-phenyloxazole
0.29 g (2.8 mmol) of triethylamine is added to a mixture of 0.5 g (2.8 mmol) of 5-phenyl-3H-oxazole-2-thione (FR 1,450,443) and 2.3 mL of phosphoryl chloride cooled to 0° C.
The mixture is heated to 120° C. for 3 hours.
The medium is diluted with ethyl acetate and washed with water.
The organic phase is dried over magnesium sulfate, filtered and concentrated.
The product is purified by silica gel chromatography (eluent: 15/85 ethyl acetate/heptane).
Chestnut brown viscous oil; Yield: 18percent 1H NMR (CDCl3): 7.7 to 7.55 (unresolved peaks, 2H); 7.5 to 7.3 (unresolved peaks, 3H); 7.25 (singlet, 1H)
Reference: [1] Patent: US2006/89364, 2006, A1, . Location in patent: Page/Page column 28-29
  • 3
  • [ 16172-23-9 ]
  • [ 62124-43-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 5, p. 1610 - 1619
  • 4
  • [ 129053-63-0 ]
  • [ 62124-43-0 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1990, vol. 99, p. 89 - 101
  • 5
  • [ 5468-37-1 ]
  • [ 62124-43-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 5, p. 1610 - 1619
  • 6
  • [ 98-88-4 ]
  • [ 62124-43-0 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1990, vol. 99, p. 89 - 101
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 62124-43-0 ]

Aryls

Chemical Structure| 1006-68-4

[ 1006-68-4 ]

5-Phenyl-1,3-oxazole

Similarity: 0.84

Chemical Structure| 1008-95-3

[ 1008-95-3 ]

4-(1,3-Oxazol-5-yl)aniline

Similarity: 0.78

Chemical Structure| 157837-31-5

[ 157837-31-5 ]

3-(5-Oxazolyl)aniline

Similarity: 0.78

Chemical Structure| 252928-82-8

[ 252928-82-8 ]

3-(5-Oxazolyl)benzoic Acid

Similarity: 0.77

Chemical Structure| 129053-70-9

[ 129053-70-9 ]

2-Bromo-5-phenyloxazole

Similarity: 0.73

Chlorides

Chemical Structure| 615-18-9

[ 615-18-9 ]

2-Chlorobenzoxazole

Similarity: 0.67

Chemical Structure| 934236-41-6

[ 934236-41-6 ]

Methyl 2-chlorooxazole-5-carboxylate

Similarity: 0.61

Chemical Structure| 3336-60-5

[ 3336-60-5 ]

1-Chloro-4-methoxyisoquinoline

Similarity: 0.60

Chemical Structure| 3621-81-6

[ 3621-81-6 ]

2,5-Dichlorobenzooxazole

Similarity: 0.60

Chemical Structure| 862599-47-1

[ 862599-47-1 ]

Ethyl 2-chlorooxazole-5-carboxylate

Similarity: 0.59

Related Parent Nucleus of
[ 62124-43-0 ]

Oxazoles

Chemical Structure| 1006-68-4

[ 1006-68-4 ]

5-Phenyl-1,3-oxazole

Similarity: 0.84

Chemical Structure| 1008-95-3

[ 1008-95-3 ]

4-(1,3-Oxazol-5-yl)aniline

Similarity: 0.78

Chemical Structure| 157837-31-5

[ 157837-31-5 ]

3-(5-Oxazolyl)aniline

Similarity: 0.78

Chemical Structure| 252928-82-8

[ 252928-82-8 ]

3-(5-Oxazolyl)benzoic Acid

Similarity: 0.77

Chemical Structure| 129053-70-9

[ 129053-70-9 ]

2-Bromo-5-phenyloxazole

Similarity: 0.73